208 related articles for article (PubMed ID: 25753853)
1. Treatment of complex periorbital venolymphatic malformation in a neonate with a combination therapy of sirolimus and prednisolone.
Kim D; Benjamin L; Wysong A; Hovsepian D; Teng J
Dermatol Ther; 2015; 28(4):218-21. PubMed ID: 25753853
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
[TBL] [Abstract][Full Text] [Related]
3. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
Shoji MK; Shishido S; Freitag SK
Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus in the Treatment of Vascular Anomalies.
Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
[No Abstract] [Full Text] [Related]
5. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review.
Wiegand S; Wichmann G; Dietz A
Lymphat Res Biol; 2018 Aug; 16(4):330-339. PubMed ID: 29924669
[TBL] [Abstract][Full Text] [Related]
6. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
[No Abstract] [Full Text] [Related]
7. Airway response to sirolimus therapy for the treatment of complex pediatric lymphatic malformations.
Alemi AS; Rosbe KW; Chan DK; Meyer AK
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2466-9. PubMed ID: 26549380
[TBL] [Abstract][Full Text] [Related]
8. Novel treatment of recurrent orbital venolymphatic malformation with sirolimus and rivaroxaban.
Purt B; Rana HS; Whitescarver TD; Chou E
Orbit; 2022 Dec; 41(6):771-778. PubMed ID: 34030590
[TBL] [Abstract][Full Text] [Related]
9. Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl.
Cardis MA; DeKlotz CMC
Pediatr Dermatol; 2018 Nov; 35(6):e406-e407. PubMed ID: 30152558
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus for the Treatment of a Massive Capillary-Lymphatico-Venous Malformation: A Case Report.
Vlahovic AM; Vlahovic NS; Haxhija EQ
Pediatrics; 2015 Aug; 136(2):e513-6. PubMed ID: 26148957
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sirolimus in children with lymphatic malformations of the head and neck.
Wiegand S; Dietz A; Wichmann G
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3801-3810. PubMed ID: 35526176
[TBL] [Abstract][Full Text] [Related]
13. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
Dodds M; Tollefson M; Castelo-Soccio L; Garzon MC; Hogeling M; Hook K; Boull C; Maguiness S
Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
[TBL] [Abstract][Full Text] [Related]
14. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
Durand R; Reid JR; Belasco JB; Shellikeri S; Calle-Toro JS; Cahill AM; Srinivasan A
AJR Am J Roentgenol; 2021 Sep; 217(3):741-752. PubMed ID: 33405944
[No Abstract] [Full Text] [Related]
15. Topical rapamycin and microcystic lymphatic malformations.
Gu Y; Sebaratnam DF
J Am Acad Dermatol; 2024 Jan; 90(1):e29-e30. PubMed ID: 37717734
[No Abstract] [Full Text] [Related]
16. Oral rapamycin: an alternative in children with complicated vascular abnormalities.
Gómez Sánchez A; Redondo Sedano JV; Pérez Alonso V; Martí Carrera ME; Baro Fernández M; Palencia Pérez SI; Gallego Herrero MC; Gómez Fraile A; Delgado Muñoz MD
Cir Pediatr; 2020 Oct; 33(4):183-187. PubMed ID: 33016658
[TBL] [Abstract][Full Text] [Related]
17. Single-center experience with sirolimus therapy for vascular malformations.
Yesil S; Tanyildiz HG; Bozkurt C; Cakmakci E; Sahin G
Pediatr Hematol Oncol; 2016 Apr; 33(3):219-25. PubMed ID: 27128161
[TBL] [Abstract][Full Text] [Related]
18. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of sirolimus in the treatment of complex lymphatic malformations: Single center report of 56 cases.
Tian R; Liang Y; Zhang W; Wang J; Shan Y; Gao H; Xie C; Li J; Xu M; Gu S
J Pediatr Surg; 2020 Nov; 55(11):2454-2458. PubMed ID: 32044101
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation.
Strychowsky JE; Rahbar R; O'Hare MJ; Irace AL; Padua H; Trenor CC
Laryngoscope; 2018 Jan; 128(1):269-276. PubMed ID: 28782106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]